Isolated oxidative phosphorylation complex disorder

Isolated oxidative phosphorylation complex disorder is a broad grouping of rare mitochondrial diseases in which a single complex of the mitochondrial respiratory chain (oxidative phosphorylation system) is deficient. The oxidative phosphorylation (OXPHOS) system consists of five enzyme complexes (Complex I through Complex V) located in the inner mitochondrial membrane, responsible for generating the majority of cellular energy in the form of ATP. When one of these complexes is deficient in isolation, it leads to impaired energy production that predominantly affects tissues with high energy demands, including the brain, skeletal muscle, heart, liver, and kidneys. Clinical presentations are highly variable depending on which complex is affected and the severity of the deficiency. Common features may include muscle weakness (myopathy), exercise intolerance, developmental delay, seizures, lactic acidosis, cardiomyopathy, hepatic dysfunction, failure to thrive, and progressive neurological deterioration. Some patients present in the neonatal period with severe, life-threatening multisystem disease, while others may have a milder course with onset in childhood or even adulthood. Leigh syndrome, a severe neurological condition, is one of the more recognized phenotypes associated with isolated OXPHOS complex deficiencies. There is currently no cure for isolated oxidative phosphorylation complex disorders. Treatment is largely supportive and symptomatic, and may include supplementation with cofactors such as coenzyme Q10, riboflavin, or thiamine, management of lactic acidosis, nutritional support, physical therapy, and treatment of organ-specific complications such as seizures or cardiac dysfunction. Genetic counseling is important given the variable inheritance patterns. Prognosis depends heavily on the specific complex involved, the genetic cause, and the organs affected.

Common questions about Isolated oxidative phosphorylation complex disorder